Lipid nanoparticles for brain targeting III. Long-term stability and in vivo toxicity
Authors:
- Paolo BlasiPBPaolo Blasi
- Aurélie SchoubbenASAurélie Schoubben
- Giovanna TrainaGiovanna Traina
- Giuseppe ManfroniGiuseppe Manfroni
- Lanfranco BarberiniLBLanfranco Barberini
- Paolo Francesco AlbertiPAPaolo Francesco Alberti
- Carlo CirottoCCCarlo Cirotto
- Maurizio RicciMRMaurizio Ricci
- 1 September 2013
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 454 (1) , 316-323
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Lipid nanoparticles for brain targeting I. Formulation optimizationInternational Journal of Pharmaceutics, 2011
- Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLCColloids and Surfaces B: Biointerfaces, 2010
- Injectable Lipid Emulsions—Advancements, Opportunities and ChallengesAAPS PharmSciTech, 2010
- Factors governing partial coalescence in oil-in-water emulsionsAdvances in Colloid and Interface Science, 2010
- Hydrogenated castor oil nanoparticles as carriers for the subcutaneous administration of tilmicosin: in vitro and in vivo studiesJournal of Veterinary Pharmacology and Therapeutics, 2009
- Potential of solid lipid nanoparticles in brain targetingJournal of Controlled Release, 2008
- Solid lipid nanoparticles for targeted brain drug delivery☆Advanced Drug Delivery Reviews, 2007
- Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticlesInternational Journal of Pharmaceutics, 2006
- Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patternsJournal of Drug Targeting, 2005
- The blood–brain barrier: an overviewNeurobiology of Disease, 2004